AmerisourceBergen Financials

ABG Stock  EUR 232.00  3.10  1.35%   
We suggest to use AmerisourceBergen fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if AmerisourceBergen is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate thirty-five available fundamental indicators for AmerisourceBergen, which can be compared to its peers. The stock experiences a large bullish trend. Check odds of AmerisourceBergen to be traded at €255.2 in 90 days.
  
Understanding current and past AmerisourceBergen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AmerisourceBergen's financial statements are interrelated, with each one affecting the others. For example, an increase in AmerisourceBergen's assets may result in an increase in income on the income statement.

AmerisourceBergen Stock Summary

AmerisourceBergen competes with Cardinal Health, Henry Schein, Sinopharm Group, SINOPHARM GROUP, and Prestige Consumer. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania. AMERISOURCEBERGEN operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21000 people.
Foreign Associate
  USA
InstrumentGermany Stock View All
ExchangeFrankfurt Exchange
ISINUS03073E1055
Business Address1 West First
SectorHealthcare
IndustryMedical Distribution
BenchmarkDow Jones Industrial
Websitewww.amerisourcebergen.com
Phone610 727 7000
CurrencyEUR - Euro
You should never invest in AmerisourceBergen without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AmerisourceBergen Stock, because this is throwing your money away. Analyzing the key information contained in AmerisourceBergen's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

AmerisourceBergen Key Financial Ratios

There are many critical financial ratios that AmerisourceBergen's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AmerisourceBergen reports annually and quarterly.

AmerisourceBergen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AmerisourceBergen's current stock value. Our valuation model uses many indicators to compare AmerisourceBergen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AmerisourceBergen competition to find correlations between indicators driving AmerisourceBergen's intrinsic value. More Info.
AmerisourceBergen is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.06  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AmerisourceBergen is roughly  17.07 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AmerisourceBergen's earnings, one of the primary drivers of an investment's value.

AmerisourceBergen Systematic Risk

AmerisourceBergen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AmerisourceBergen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on AmerisourceBergen correlated with the market. If Beta is less than 0 AmerisourceBergen generally moves in the opposite direction as compared to the market. If AmerisourceBergen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AmerisourceBergen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AmerisourceBergen is generally in the same direction as the market. If Beta > 1 AmerisourceBergen moves generally in the same direction as, but more than the movement of the benchmark.

AmerisourceBergen January 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AmerisourceBergen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AmerisourceBergen. We use our internally-developed statistical techniques to arrive at the intrinsic value of AmerisourceBergen based on widely used predictive technical indicators. In general, we focus on analyzing AmerisourceBergen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AmerisourceBergen's daily price indicators and compare them against related drivers.

Complementary Tools for AmerisourceBergen Stock analysis

When running AmerisourceBergen's price analysis, check to measure AmerisourceBergen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AmerisourceBergen is operating at the current time. Most of AmerisourceBergen's value examination focuses on studying past and present price action to predict the probability of AmerisourceBergen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AmerisourceBergen's price. Additionally, you may evaluate how the addition of AmerisourceBergen to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities